Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial

Haering, Hans-Ulrich; Merker, Ludwig; Seewaldt-Becker, Elke; Weimer, Marc; Meinicke, Thomas; Woerle, Hans J.; Broedl, Uli C.

dc.contributor.author	Häring, Hans-Ulrich
dc.date.accessioned	2014-04-01T12:43:41Z
dc.date.available	2014-04-01T12:43:41Z
dc.date.issued	2013
dc.identifier.issn	0149-5992
dc.identifier.uri	http://hdl.handle.net/10900/50760
dc.language.iso	en	de_DE
dc.publisher	Amer Diabetes Assoc	de_DE
dc.relation.uri	http://dx.doi.org/10.2337/dc12-2673	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140116051827_00306	de_DE
utue.publikation.seiten	3396-3404	de_DE
utue.personen.roh	Haering, Hans-Ulrich
utue.personen.roh	Merker, Ludwig
utue.personen.roh	Seewaldt-Becker, Elke
utue.personen.roh	Weimer, Marc
utue.personen.roh	Meinicke, Thomas
utue.personen.roh	Woerle, Hans J.
utue.personen.roh	Broedl, Uli C.
dcterms.isPartOf.ZSTitelID	Diabetes Care	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	36	de_DE